These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4854531)

  • 1. Suppression and enhancement of allografted tumour.
    Yutoku M; Seno H; Matsuoka Y; Kitagawa M
    Immunology; 1974 Mar; 26(3):623-37. PubMed ID: 4854531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytotoxic lymphocytes and anti-tumor immunity].
    Cerottini JC; Brunner KT
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitation of in vivo growth of plasmacytoma X5563 by immunoassay for its paraprotein with individual antigenic specificity.
    Yutoku M; Seno H; Watanabe S; Matsuoka Y; Kitagawa M
    J Natl Cancer Inst; 1972 Nov; 49(5):1395-402. PubMed ID: 4119497
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxicity of murine peritoneal macrophages in tumour allograft immunity.
    Den Otter W; Evans R; Alexander P
    Transplantation; 1972 Aug; 14(2):220-6. PubMed ID: 4114971
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro testing of enhancement.
    Bansal SC; Sjögren HO
    Transplant Proc; 1972 Dec; 4(4):509-12. PubMed ID: 4566795
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response.
    Rouse BT; Röllinghoff M; Warner NL
    Eur J Immunol; 1973 Apr; 3(4):218-24. PubMed ID: 4541468
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cellular immunity in mouse plasmocytomas].
    Lespinats G; Poupon MF
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):755-65. PubMed ID: 5050876
    [No Abstract]   [Full Text] [Related]  

  • 8. Preliminary observations on immunity in BALB-c mice to myeloma tumor of BALB-c origin.
    Shearer WT; Graff RJ; Eisen HN
    Transplantation; 1972 Mar; 13(3):345-7. PubMed ID: 5021442
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of immunological enhancement.
    Cruse JM; Lewis GK; Whitten HD; Watson ES; Fields JF; Adams ST; Harvey GF; Paslay JW; Porter M
    Prog Exp Tumor Res; 1974; 19():110-56. PubMed ID: 4140539
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunity to infection, allograft immunity and tumour immunity: parallels and contrasts.
    Nelson DS
    Transplant Rev; 1974; 19(0):226-54. PubMed ID: 4152202
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of resistance or enhancement to a transplantable murine plasmacytoma by transfer of non-immune leucocytes.
    Giovarelli M; Comoglio PM; Forni G
    Br J Cancer; 1976 Sep; 34(3):233-8. PubMed ID: 788762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase-induced enhancement of tumor growth in mice.
    Froese G; Berczi I; Sehon AH
    J Natl Cancer Inst; 1974 Jun; 52(6):1905-8. PubMed ID: 4834417
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
    Kieler J
    Ser Haematol; 1972; 5(4):93-122. PubMed ID: 4133765
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.
    Röllinghoff M; Rouse BT; Warner NL
    J Natl Cancer Inst; 1973 Jan; 50(1):159-72. PubMed ID: 4571237
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunologic enhancement induced by antibody fragments.
    Cruse JM; Forbes JT; Gillespie GY; Lewis GK
    Z Immunitatsforsch Allerg Klin Immunol; 1970; 140(3):259-67. PubMed ID: 4251393
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of macrophages in tumour immunity. 3. Co-operation between macrophages and lymphoid factors in an in vitro allograft situation.
    Evans R; Grant CK
    Immunology; 1972 Nov; 23(5):677-87. PubMed ID: 4673868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the anti-plasma cell serum. I. Selective suppression of gamma-2 hemolysin in mice.
    Nariuchi H; Usui M; Fujimoto Y; Hirokawa K; Matuhasi T
    Int Arch Allergy Appl Immunol; 1971; 40(4-5):590-602. PubMed ID: 4996087
    [No Abstract]   [Full Text] [Related]  

  • 18. [Complement-dependent immune cytolysis of cells from transplantable myeloid tumor].
    Iakimov M
    Acta Microbiol Virol Immunol (Sofiia); 1975; 2():52-6. PubMed ID: 175643
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
    Rouse BT; Wagner H; Harris AW
    J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of castration and oestradiol treatment on tumor transplantation immunity in mice.
    Peter HH; Chouroulinkov I; Guillon JC; Ventura A; Lenormand M
    Z Krebsforsch; 1970; 74(2):207-18. PubMed ID: 4103129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.